two new inhalers for COPD, Anoro Ellipta (a-NOR-oh ee-LIP-ta) and Ultibro Breezhaler (UHL-tee-broh BREEZE-hale-er)

April 2014

You'll see two new inhalers for COPD, Anoro Ellipta (a-NOR-oh ee-LIP-ta) and Ultibro Breezhaler (UHL-tee-broh BREEZE-hale-er).

They're the first inhalers to combine TWO "long-acting bronchodilators" to prevent coughing, wheezing, and other breathing problems in COPD patients.

Anoro is a combination of umeclidinium and vilanterol...and Ultibro is a combination of glycopyrronium and indacaterol.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Respiratory & Allergy Nebulizer solutions (salbutamol, ipratropium, etc) are still causing confusion
Heart Failure more focus on preventing mix-ups among digoxin products
Inhalers two new inhalers for COPD, Anoro Ellipta (a-NOR-oh ee-LIP-ta) and Ultibro Breezhaler (UHL-tee-broh BREEZE-hale-er)
Mood Stabilizers Health Canada is warning about the possibility that lithium might increase a patient's blood level of calcium
Diabetes emphasis on improving care in diabetes patients
Pediatrics dexamethasone for asthma exacerbations
Vaccines a new meningitis vaccine, Bexsero (BEX-sare-roe)
Hypertension when to treat SEVERE hypertension
Pregnancy whether acetaminophen is risky during pregnancy
Stroke more focus on preventing strokes in YOUNGER WOMEN
Controlled Substances how to handle controlled substance Rxs for patients with a "pain contract" or treatment agreement